NSEAction(s) taken or orders passed3h ago · 3 Oct 2026, 05:15 pm
Action(s) taken or orders passed
Dr. Reddy's Laboratories Limited · DRREDDY
✦ AI SummaryRegulatory
Dr. Reddy's Laboratories Limited has informed the Exchange about imposition of a penalty of $32,350.20 to its step-down wholly owned subsidiary, Dr. Reddy's Laboratories, Inc., due to misclassification of Fiscal year reference at the time of tax payment.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Reddy's Laboratories Limited has informed the Exchange about imposition of penalty to Dr. Reddy s Laboratories, Inc. ( DRL Inc ), a step-down wholly owned subsidiary of the Company.
Attachments (1)
📄pdf
Download →
DRREDDY_03102026171508_SE_intimation_03102026_signed.pdf
View document text
Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills
Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900
Fax: + 91 40 4900 2999
Email: mail@drreddys.com
Web: www.drreddys.com
October 3,2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
This is to inform that Dr. Reddy’s Laboratories, Inc. (“DRL Inc”), a step-down wholly owned subsidiary
of the Company, received final transcript dated September 25, 2026, from Department of the Treasury,
Internal Revenue Service, Cincinnati, OH, US (“IRS”) on Oct 2,2026 classifying an amount $32,350.20
as a penalty levied by IRS. The details as required under Regulation 30 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 read with Schedule III Para A Sub Para 20 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015 are as hereunder:
Name of the authority Department of Treasury, Internal Revenue
Service, Cincinnati, OH, US
Nature and details of the action(s) taken, Penalty amount of $32,350.20 due to
initiated or order(s) passed misclassification of Fiscal year reference at the
time of tax payment.
Date of receipt of direction or order, Transcript dated Sept 25,2026 was received by
including any ad-interim or interim orders, DRL Inc. on Oct 2,2026.
or any other communication from the
authority
Details of the violation(s)/ Penalty due to misclassification of Fiscal year
contravention(s) committed or alleged reference at the time of tax payment.
to be committed
Impact on financial, operation or other Based on our evaluation, there is no material
activities of the listed entity, quantifiable in impact on financials, operations or other activities
monetary terms to the extent possible
of the Company.
This is for your information and record.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer and Head-CSR